Saturday review: Opiant Pharmaceuticals, Johnson Matthey and HSBC

There were plenty of bits and pieces going on yesterday afternoon that little old Betaville wasn't able to get on top of as I was rather busy, so I thought I would chew over them today in the Saturday review.

One story that was brought to my attention was the bizarre goings on at Opiant Pharmaceuticals, a US-listed firm that makes medicines for the treatment of addictions...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Saturday, 30 April 2022, 10:20 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation